| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 12/13/2001 | CA2591583A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2585822A1 Breast, rectal, colon and lung tumour marker pro19628 polypeptide and encoding nucleic acid |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2412374A1 Novel leader peptides for enhancing secretion of recombinant protein from a host cell |
| 12/13/2001 | CA2411730A1 Tumour suppressor and uses thereof |
| 12/13/2001 | CA2411719A1 Novel g-protein coupled receptor |
| 12/13/2001 | CA2411541A1 High level production of p-hydroxybenzoic acid in green plants |
| 12/13/2001 | CA2411470A1 T cell receptor fusions and conjugates and methods of use thereof |
| 12/13/2001 | CA2409287A1 Hepatitis c virus conjugates |
| 12/12/2001 | EP1162264A2 Chimeric hormone receptor |
| 12/12/2001 | EP1161550A1 Target cell-specific, multivalent proteins (mvp) |
| 12/12/2001 | EP1161456A2 Antibody and chemokine constructs and their use for treating autoimmune diseases |
| 12/12/2001 | EP1161455A1 A novel chimeric protein for prevention and treatment of hiv infection |
| 12/12/2001 | EP1161454A2 Peptides with anti-angiogenic activity |
| 12/12/2001 | EP1161261A1 Apoptosis inducing molecule ii and methods of use |
| 12/12/2001 | CN1326467A Expression and export of angiostation and endostatin as immunofusins |
| 12/12/2001 | CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells |
| 12/11/2001 | US6329336 Glue and crosslinking agent using albumin |
| 12/11/2001 | US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues |
| 12/11/2001 | US6328973 Method of raising neutralizing antibodies against HIV |
| 12/11/2001 | US6328962 Conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody and expression in mammal cells to produce the conjugated antibody; enhanced immune response |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2065874C Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 12/06/2001 | WO2001092584A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 12/06/2001 | WO2001092501A1 Improved nucleic acid modifying enzymes |
| 12/06/2001 | WO2001092469A2 Phosphorylated polypeptides and uses related thereto |
| 12/06/2001 | WO2001092452A1 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 12/06/2001 | WO2001092337A2 Soluble ctla4 mutant molecules and uses thereof |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092306A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092300A2 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | WO2001068805A8 Human olfactory receptors and genes encoding same |
| 12/06/2001 | WO2001064922A3 Heterologous expression of neisserial proteins |
| 12/06/2001 | WO2001057216A3 Method for the production of a protein |
| 12/06/2001 | WO2001046224A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001032864A3 Gpcr-kd5 polypeptides and dna sequences thereof |
| 12/06/2001 | WO2001023421B1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 12/06/2001 | US20010049122 For reducing inflammation, for treating an autoimmune disease, for enhancing transplantation of tissue grafts, increasing antitumor immunity, and inhibiting viral and parasitic infections |
| 12/06/2001 | CA2411304A1 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410895A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410754A1 Phosphorylated polypeptides and uses related thereto |
| 12/06/2001 | CA2409417A1 Improved nucleic acid modifying enzymes |
| 12/06/2001 | CA2408226A1 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 12/05/2001 | EP1160323A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 12/05/2001 | EP1160322A2 Human melanocyte stimulating hormone receptors |
| 12/05/2001 | EP1159422A1 Compositions and methods for the treatment of tumors |
| 12/05/2001 | EP1159419A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 12/05/2001 | EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 12/05/2001 | EP1159328A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 12/05/2001 | EP1159299A1 Mammalian cytokines; related reagents and methods |
| 12/05/2001 | EP1158993A1 Bacterial membrane fractions with adjuvant effect |
| 12/05/2001 | EP0783522B1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 12/05/2001 | CN1325447A Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 12/05/2001 | CN1325405A Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 12/05/2001 | CN1324803A Efficient production process and application of BPI-Fc recombinant protein |
| 12/04/2001 | US6326467 Peptide hormones, lh-rh |
| 12/04/2001 | US6326179 Enzymatic immunoglobulin; for use as therapeutic and diagnostic tools in treatment of arthritis, viral disease and alzheimer's disease |
| 12/04/2001 | US6326159 Receptors for immune complexes |
| 12/04/2001 | CA2117581C Protocadherin, their antibodies and uses |
| 12/04/2001 | CA2053829C Vaccines against equine herpesviruses and the preparation thereof |
| 11/29/2001 | WO2001090359A2 G-protein coupled receptors |
| 11/29/2001 | WO2001090358A2 Mammalian receptor proteins; related reagents and methods |
| 11/29/2001 | WO2001090334A2 Drug metabolizing enzymes |
| 11/29/2001 | WO2001090197A1 Synthetic peptides and uses therefore |
| 11/29/2001 | WO2001090182A2 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 11/29/2001 | WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 11/29/2001 | WO2001090153A2 Reagents for cell selection and methods of use |
| 11/29/2001 | WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 11/29/2001 | WO2001090151A2 Human receptor proteins; related reagents and methods |
| 11/29/2001 | WO2001090147A2 Long wavelength engineered fluorescent proteins |
| 11/29/2001 | WO2001090143A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 11/29/2001 | WO2001089286A2 T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders |
| 11/29/2001 | WO2001040257A3 Modified il-12 subunits and nucleic acids encoding them |
| 11/29/2001 | WO2001038566A3 Screening method for candidate drugs |
| 11/29/2001 | WO2001016318A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/29/2001 | US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides |
| 11/29/2001 | US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors |
| 11/29/2001 | US20010047080 Inhibits hiv infection of cells |
| 11/29/2001 | US20010046495 Use of cross-linked, covalently bound urokinase plasminogen activator (scuPAR)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent |
| 11/29/2001 | US20010046490 Cell surface molecule-induced macrophage activation |
| 11/29/2001 | CA2429199A1 Drug metabolizing enzymes |
| 11/29/2001 | CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 11/29/2001 | CA2410083A1 Mammalian receptor proteins; related reagents and methods |
| 11/29/2001 | CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods |
| 11/29/2001 | CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 11/29/2001 | CA2408925A1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 11/29/2001 | CA2408302A1 Long wavelength engineered fluorescent proteins |
| 11/29/2001 | CA2408140A1 G-protein coupled receptors |
| 11/29/2001 | CA2408125A1 Synthetic peptides and uses therefore |
| 11/28/2001 | EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 11/28/2001 | EP1157122A1 Anti-neoplastic compositions and uses thereof |
| 11/28/2001 | EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 11/28/2001 | EP1156817A1 Controlling protein levels in eucaryotic organisms |
| 11/28/2001 | EP0804215B1 Template assembled synthetic protein |
| 11/28/2001 | EP0460190B2 Method for detecting malignant diseases |
| 11/28/2001 | CN1324242A Novel NEUROPILIN/growth factor binding and use thereof |
| 11/27/2001 | US6323323 Ligand-binding, dimerized polypeptide fusions |
| 11/27/2001 | US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
| 11/27/2001 | CA2074837C Methods of producing hybrid g protein-coupled receptors |